Clinical feature	Statistical test	Significant miRs	Associated with	               	Associated with	
Time to Death	Cox regression test	N=13	shorter survival	N=9	longer survival	N=4
AGE	Spearman correlation test	N=18	older	N=9	younger	N=9
NEOPLASM DISEASESTAGE	Kruskal-Wallis test	N=54	 	 	 	 
PATHOLOGY T STAGE	Spearman correlation test	N=39	higher stage	N=19	lower stage	N=20
PATHOLOGY N STAGE	Wilcoxon test	N=101	class1	N=101	class0	N=0
PATHOLOGY M STAGE	Kruskal-Wallis test	N=14	 	 	 	 
GENDER	Wilcoxon test	N=2	male	N=2	female	N=0
HISTOLOGICAL TYPE	Kruskal-Wallis test	N=206	 	 	 	 
RADIATIONS RADIATION REGIMENINDICATION	Wilcoxon test	N=26	yes	N=26	no	N=0
RADIATIONEXPOSURE	Wilcoxon test	N=0	 	 	 	 
EXTRATHYROIDAL EXTENSION	Kruskal-Wallis test	N=80	 	 	 	 
COMPLETENESS OF RESECTION	Kruskal-Wallis test	N=3	 	 	 	 
NUMBER OF LYMPH NODES	Spearman correlation test	N=69	higher number.of.lymph.nodes	N=43	lower number.of.lymph.nodes	N=26
MULTIFOCALITY	Wilcoxon test	N=1	unifocal	N=1	multifocal	N=0
TUMOR SIZE	Spearman correlation test	N=14	higher tumor.size	N=5	lower tumor.size	N=9
RACE	Kruskal-Wallis test	N=6	 	 	 	 
ETHNICITY	Wilcoxon test	N=5	not hispanic or latino	N=5	hispanic or latino	N=0